Events

Dr. Iris Hecht, Principal Scientist, will review results for CGEN-15001, a fusion protein based on immune checkpoint candidate discovered by the Company at the Immune Tolerance 2014 conference

Amsterdam, The Netherlands

Sep 28, 2014 - Sep 20, 2014
MORE EVENTS